117 related articles for article (PubMed ID: 7380914)
1. Origin of the two peaks for 2-keto-3-methylvaleric acid produced by the oximation of the keto acids occurring in maple syrup urine disase.
Mamer OA; Montgomery JA; Taguchi VY
J Chromatogr; 1980 May; 182(2):221-5. PubMed ID: 7380914
[No Abstract] [Full Text] [Related]
2. Branched-chain alpha-keto acids isolated as oxime derivatives: relationship to the corresponding hydroxy acids and amino acids in maple syrup urine disease.
Lancaster G; Mamer OA; Scriver CR
Metabolism; 1974 Mar; 23(3):257-65. PubMed ID: 4813956
[No Abstract] [Full Text] [Related]
3. Determination of alpha-keto acids as silylated oximes in urine and serum by combined gas chromatography-mass spectrometry.
Sternowsky HJ; Roboz J; Hutterer F; Gaull G
Clin Chim Acta; 1973 Sep; 47(3):371-9. PubMed ID: 4795614
[No Abstract] [Full Text] [Related]
4. Synaptic plasma membrane Na(+), K (+)-ATPase activity is significantly reduced by the alpha-keto acids accumulating in maple syrup urine disease in rat cerebral cortex.
Wajner A; Bürger C; Dutra-Filho CS; Wajner M; de Souza Wyse AT; Wannmacher CM
Metab Brain Dis; 2007 Mar; 22(1):77-88. PubMed ID: 17295076
[TBL] [Abstract][Full Text] [Related]
5. On the mechanisms of the formation of L-alloisoleucine and the 2-hydroxy-3-methylvaleric acid stereoisomers from L-isoleucine in maple syrup urine disease patients and in normal humans.
Mamer OA; Reimer ML
J Biol Chem; 1992 Nov; 267(31):22141-7. PubMed ID: 1429566
[TBL] [Abstract][Full Text] [Related]
6. Quantitative analysis of branched-chain alpha-keto acids as their trimethylsilylated oximes.
Lancaster G; Lamm P; Scriver CR; Tjoa SS; Mamer OA
Clin Chim Acta; 1973 Oct; 48(3):279-85. PubMed ID: 4765708
[No Abstract] [Full Text] [Related]
7. Gas-liquid chromatography of alpha-keto acids: quantification of the branched-chain-alpha-keto acids from physiological sources.
Cree TC; Hutson SM; Harper AE
Anal Biochem; 1979 Jan; 92(1):159-63. PubMed ID: 426274
[No Abstract] [Full Text] [Related]
8. Inhibition of brain energy metabolism by the alpha-keto acids accumulating in maple syrup urine disease.
Sgaravatti AM; Rosa RB; Schuck PF; Ribeiro CA; Wannmacher CM; Wyse AT; Dutra-Filho CS; Wajner M
Biochim Biophys Acta; 2003 Nov; 1639(3):232-8. PubMed ID: 14636955
[TBL] [Abstract][Full Text] [Related]
9. Intrahippocampal administration of the alpha-keto acids accumulating in maple syrup urine disease provokes learning deficits in rats.
de Castro Vasques V; de Boer MA; Diligenti F; Brinco F; Mallmann F; Mello CF; Wajner M
Pharmacol Biochem Behav; 2004 Jan; 77(1):183-90. PubMed ID: 14724056
[TBL] [Abstract][Full Text] [Related]
10. The gas-chromatographic diagnosis of intermittent maple syrup urine disease (branch-chain ketoaciduria).
Gompertz D; Draffan GH
Clin Chim Acta; 1972 Aug; 40(1):5-11. PubMed ID: 5056643
[No Abstract] [Full Text] [Related]
11. Prevention of DNA damage by L-carnitine induced by metabolites accumulated in maple syrup urine disease in human peripheral leukocytes in vitro.
Mescka CP; Wayhs CA; Guerreiro G; Manfredini V; Dutra-Filho CS; Vargas CR
Gene; 2014 Sep; 548(2):294-8. PubMed ID: 25046137
[TBL] [Abstract][Full Text] [Related]
12. Determination of (S)- and (R)-2-oxo-3-methylvaleric acid in plasma of patients with maple syrup urine disease.
Wendel U; Even G; Langenbeck U; Schadewaldt P; Hummel W
Clin Chim Acta; 1992 Jun; 208(1-2):85-91. PubMed ID: 1638756
[TBL] [Abstract][Full Text] [Related]
13. [A case of maple syrup urine disease. Biochemical study].
Lamedica GM; Fregonese B; Moroni G; Famularo L
Minerva Pediatr; 1972 Dec; 24(43):2143-9. PubMed ID: 4652219
[No Abstract] [Full Text] [Related]
14. Evidence that the branched-chain alpha-keto acids accumulating in maple syrup urine disease induce morphological alterations and death in cultured astrocytes from rat cerebral cortex.
Funchal C; Gottfried C; De Almeida LM; Wajner M; Pessoa-Pureur R
Glia; 2004 Nov; 48(3):230-40. PubMed ID: 15390119
[TBL] [Abstract][Full Text] [Related]
15. Reduction of glutamate uptake into cerebral cortex of developing rats by the branched-chain alpha-keto acids accumulating in maple syrup urine disease.
Funchal C; Rosa AM; Wajner M; Wofchuk S; Pureur RP
Neurochem Res; 2004 Apr; 29(4):747-53. PubMed ID: 15098937
[TBL] [Abstract][Full Text] [Related]
16. Prepurification and derivatization of alpha-keto acids using hydrazide gel. Application in gas chromatography and gas chromatography--mass spectrometry.
Todoriki H; Hayashi T; Naruse H; Ikeda S
J Chromatogr; 1982 Nov; 232(2):394-9. PubMed ID: 6818241
[No Abstract] [Full Text] [Related]
17. [Clinical characteristics and analysis of mass spectrometric data in 33 patients with maple syrup urine disease].
Yang N; Han LS; Ye J; Qiu WJ; Zhang HW; Gao XL; Wang Y; Li XY; Xu H; Gu XF
Zhonghua Yi Xue Za Zhi; 2012 Oct; 92(40):2839-42. PubMed ID: 23290213
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of lipid peroxidation in vitro in rat brain by the metabolites accumulating in maple syrup urine disease.
Fontella FU; Gassen E; Pulrolnik V; Wannmacher CM; Klein AB; Wajner M; Dutra-Filho CS
Metab Brain Dis; 2002 Mar; 17(1):47-54. PubMed ID: 11894849
[TBL] [Abstract][Full Text] [Related]
19. Effect of the branched-chain alpha-keto acids accumulating in maple syrup urine disease on S100B release from glial cells.
Funchal C; Tramontina F; Quincozes dos Santos A; Fraga de Souza D; Gonçalves CA; Pessoa-Pureur R; Wajner M
J Neurol Sci; 2007 Sep; 260(1-2):87-94. PubMed ID: 17499767
[TBL] [Abstract][Full Text] [Related]
20. The configuration of the alloisoleucine present in maple syrup urine disease plasma.
Halpern B; Pollock GE
Biochem Med; 1970 Nov; 4(3):352-6. PubMed ID: 5524075
[No Abstract] [Full Text] [Related]
[Next] [New Search]
